Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141304 |
| CAS No | NA |
| Mol.F. | C16H18N2O4 |
| Mol.Wt. | 302.3 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141302 |
| CAS No | NA |
| Mol.F. | C12H13N3O3 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141305 |
| CAS No | NA |
| Mol.F. | C16H18N2O4 |
| Mol.Wt. | 302.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141306 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141307 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141308 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141309 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141310 |
| CAS No | NA |
| Mol.F. | C17H20N2O4 |
| Mol.Wt. | 316.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141311 |
| CAS No | NA |
| Mol.F. | C10H13N3O3 |
| Mol.Wt. | 223.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141312 |
| CAS No | NA |
| Mol.F. | C13H18N2O2 |
| Mol.Wt. | 234.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141313 |
| CAS No | NA |
| Mol.F. | C20H27N3O6 |
| Mol.Wt. | 405.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141314 |
| CAS No | NA |
| Mol.F. | C21H26N2O6 |
| Mol.Wt. | 402.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141315 |
| CAS No | 3050754-69-0 |
| Mol.F. | C14H21N3O3 |
| Mol.Wt. | 279.34 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141316 |
| CAS No | NA |
| Mol.F. | C16H11BrClFN4O3 |
| Mol.Wt. | 441.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141317 |
| CAS No | 16339-21-2 |
| Mol.F. | C7H14N2O2 |
| Mol.Wt. | 158.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141318 |
| CAS No | 86022-93-7 |
| Mol.F. | C10H14N2O |
| Mol.Wt. | 178.2 |
| INV STATUS | In Stock |